000 | 01914 a2200565 4500 | ||
---|---|---|---|
005 | 20250517131328.0 | ||
264 | 0 | _c20170807 | |
008 | 201708s 0 0 eng d | ||
022 | _a1476-5586 | ||
024 | 7 |
_a10.1016/j.neo.2016.11.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRbah-Vidal, Latifa | |
245 | 0 | 0 |
_aTheranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy. _h[electronic resource] |
260 |
_bNeoplasia (New York, N.Y.) _c01 2017 |
||
300 |
_a17-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIodine Radioisotopes _xchemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelanoma _xdiagnostic imaging |
650 | 0 | 4 | _aMelanoma, Experimental |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMultimodal Imaging |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 | _aRadiochemistry |
650 | 0 | 4 |
_aRadiopharmaceuticals _xchemistry |
650 | 0 | 4 |
_aTheranostic Nanomedicine _xmethods |
650 | 0 | 4 | _aTissue Distribution |
650 | 0 | 4 | _aTumor Protein, Translationally-Controlled 1 |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aVidal, Aurélien | |
700 | 1 | _aBillaud, Emilie M F | |
700 | 1 | _aBesse, Sophie | |
700 | 1 | _aRanchon-Cole, Isabelle | |
700 | 1 | _aMishellany, Florence | |
700 | 1 | _aPerrot, Yann | |
700 | 1 | _aMaigne, Lydia | |
700 | 1 | _aMoins, Nicole | |
700 | 1 | _aGuerquin-Kern, Jean-Luc | |
700 | 1 | _aDegoul, Françoise | |
700 | 1 | _aChezal, Jean-Michel | |
700 | 1 | _aAuzeloux, Philippe | |
700 | 1 | _aMiot-Noirault, Elisabeth | |
773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 19 _gno. 1 _gp. 17-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neo.2016.11.001 _zAvailable from publisher's website |
999 |
_c26707071 _d26707071 |